This website is updated on a regular basis to reflect the most current information available. However, national public health authorities may issue additional or more detailed guidance. Users are advice to consult national websites and official sources for the most up-to-date recommendations in addition to this website.

This website does not include recommendations regarding respiratory syncytial virus long-acting monoclonal antibodies (RSV mAbs). For the latest scientific advice on RSV mAbs, please refer to the following ECDC resource: “Rapid scientific advice on protecting infants against respiratory syncytial virus disease for the European 2025/26 winter season”.

Visit the European Vaccination Information Portal (EVIP) to learn more about the benefits, effectiveness and safety of vaccines.

Please inform ECDC of incorrect or missing information at: vpd@ecdc.europa.eu. This platform was developed by ECDC with MesVaccins.net.